compound 16 [PMID: 31977207]   Click here for help

GtoPdb Ligand ID: 10650

Compound class: Synthetic organic
Comment: Compound 16 (acidified with fumaric acid) is reported as an activator of pyruvate kinase M2 (PKM2) that has in vivo anti-tumour activity against glioblastoma multiforme xenografts [1]. It is a prodrug, with the active form being compound 5 in the discovery article.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 0
Rotatable bonds 14
Topological polar surface area 145.97
Molecular weight 716.39
XLogP 1.45
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CC1C(=O)O[C@H]2[C@H]1CC/C(=C\CC[C@@]1([C@H]2O1)C)/C(=O)OCCOCCOC(=O)/C/1=C/CC[C@@]2(C)O[C@H]2[C@@H]2[C@@H](CC1)[C@H](CN(C)C)C(=O)O2)C
Isomeric SMILES CN(CC1C(=O)O[C@H]2[C@H]1CC/C(=C\CC[C@@]1([C@H]2O1)C)/C(=O)OCCOCCOC(=O)/C/1=C/CC[C@@]2(C)O[C@H]2[C@@H]2[C@@H](CC1)[C@H](CN(C)C)C(=O)O2)C
InChI InChI=1S/C38H56N2O11/c1-37-15-7-9-23(11-13-25-27(21-39(3)4)35(43)48-29(25)31(37)50-37)33(41)46-19-17-45-18-20-47-34(42)24-10-8-16-38(2)32(51-38)30-26(14-12-24)28(22-40(5)6)36(44)49-30/h9-10,25-32H,7-8,11-22H2,1-6H3/b23-9+,24-10+/t25-,26-,27-,28?,29-,30-,31-,32-,37+,38+/m0/s1
InChI Key ZNXWRMSQZDHKCM-SBRQVZBJSA-N
Bioactivity Comments
The value in the table below is that provided for compound 5 in [1]. This exhibited poor water solubility, so was converted to prodrug 16 for in vivo evaluations. An in vitro AC50 value for the prodrug 16 is not provided. In an in vitro model of the blood-brain-barrier (BBB), compound 16 transiently lowers the barrier integrity which indicates that it has the potential to penetrate the BBB
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
pyruvate kinase M1/2 Hs Activator Activation ~7.8 pEC50 - 1
pEC50 ~7.8 (EC50 ~1.5x10-8 M) [1]
Description: Activation of PKM2 kinase activity (promotion of high kinase activity PKM2 tertramer formation) in vitro, by compound 5; described as AC50 in the reference,